151 related articles for article (PubMed ID: 25252639)
1. Evidence of LAT1 expression in canine caput epididymis.
Ogihara K; Onda K; Sato R; Naya Y; Ochiai H
J Vet Med Sci; 2015 Jan; 77(1):85-8. PubMed ID: 25252639
[TBL] [Abstract][Full Text] [Related]
2. L-type amino acid transporter 1 (LAT1) expression in canine mammary gland tumors.
Fukumoto S; Hanazono K; Komatsu T; Iwano H; Kadosawa T; Uchide T
J Vet Med Sci; 2013 May; 75(4):431-7. PubMed ID: 23171689
[TBL] [Abstract][Full Text] [Related]
3. L-type amino acid transporter 1 (LAT1): a new therapeutic target for canine mammary gland tumour.
Fukumoto S; Hanazono K; Komatsu T; Ueno H; Kadosawa T; Iwano H; Uchide T
Vet J; 2013 Oct; 198(1):164-9. PubMed ID: 23896327
[TBL] [Abstract][Full Text] [Related]
4. A new treatment for human malignant melanoma targeting L-type amino acid transporter 1 (LAT1): a pilot study in a canine model.
Fukumoto S; Hanazono K; Fu DR; Endo Y; Kadosawa T; Iwano H; Uchide T
Biochem Biophys Res Commun; 2013 Sep; 439(1):103-8. PubMed ID: 23954667
[TBL] [Abstract][Full Text] [Related]
5. Canine Lat1: molecular structure, distribution and its expression in cancer samples.
Ochiai H; Morishita T; Onda K; Sugiyama H; Maruo T
J Vet Med Sci; 2012 Jul; 74(7):917-22. PubMed ID: 22322188
[TBL] [Abstract][Full Text] [Related]
6. Analysis of L-type amino acid transporter in canine hepatocellular carcinoma.
Ogihara K; Naya Y; Sato R; Onda K; Ochiai H
J Vet Med Sci; 2015 May; 77(5):527-34. PubMed ID: 25649314
[TBL] [Abstract][Full Text] [Related]
7. L-type amino acid transporter-1 expressed in human astrocytomas, U343MGa.
Asano S; Kameyama M; Oura A; Morisato A; Sakai H; Tabuchi Y; Chairoungdua A; Endou H; Kanai Y
Biol Pharm Bull; 2007 Mar; 30(3):415-22. PubMed ID: 17329830
[TBL] [Abstract][Full Text] [Related]
8. The RNA interference of amino acid transporter LAT1 inhibits the growth of KB human oral cancer cells.
Kim CH; Park KJ; Park JR; Kanai Y; Endou H; Park JC; Kim DK
Anticancer Res; 2006; 26(4B):2943-8. PubMed ID: 16886618
[TBL] [Abstract][Full Text] [Related]
9. Involvement of LAT1 and LAT2 in the high- and low-affinity transport of L-leucine in human retinal pigment epithelial cells (ARPE-19 cells).
Yamamoto A; Akanuma S; Tachikawa M; Hosoya K
J Pharm Sci; 2010 May; 99(5):2475-82. PubMed ID: 19890975
[TBL] [Abstract][Full Text] [Related]
10. LAT1 expression in non-small-cell lung carcinomas: analyses by semiquantitative reverse transcription-PCR (237 cases) and immunohistochemistry (295 cases).
Takeuchi K; Ogata S; Nakanishi K; Ozeki Y; Hiroi S; Tominaga S; Aida S; Matsuo H; Sakata T; Kawai T
Lung Cancer; 2010 Apr; 68(1):58-65. PubMed ID: 19559497
[TBL] [Abstract][Full Text] [Related]
11. Transport of Pregabalin Via L-Type Amino Acid Transporter 1 (SLC7A5) in Human Brain Capillary Endothelial Cell Line.
Takahashi Y; Nishimura T; Higuchi K; Noguchi S; Tega Y; Kurosawa T; Deguchi Y; Tomi M
Pharm Res; 2018 Oct; 35(12):246. PubMed ID: 30374619
[TBL] [Abstract][Full Text] [Related]
12. PET Imaging of L-Type Amino Acid Transporter (LAT1) and Cystine-Glutamate Antiporter (x
Krys D; Mattingly S; Glubrecht D; Wuest M; Wuest F
Mol Imaging Biol; 2020 Dec; 22(6):1562-1571. PubMed ID: 32789819
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic inhibition of LAT1 predominantly suppresses transport of large neutral amino acids and downregulates global translation in cancer cells.
Nishikubo K; Ohgaki R; Okanishi H; Okuda S; Xu M; Endou H; Kanai Y
J Cell Mol Med; 2022 Oct; 26(20):5246-5256. PubMed ID: 36071551
[TBL] [Abstract][Full Text] [Related]
14. Expression of L-type amino acid transporter 1 in canine and feline intracranial tumors.
Utsugi S; Ogihara K; Naya Y; Sunden Y; Nakamoto Y; Okamoto Y
J Vet Med Sci; 2022 Aug; 84(8):1111-1117. PubMed ID: 35753782
[TBL] [Abstract][Full Text] [Related]
15. Developmental regulation of the rabbit blood-brain barrier LAT1 large neutral amino acid transporter mRNA and protein.
Boado RJ; Li JY; Pardridge WM
Pediatr Res; 2004 Apr; 55(4):557-60. PubMed ID: 14764922
[TBL] [Abstract][Full Text] [Related]
16. Expression of L-type amino acid transporter 1 is a poor prognostic factor for Non-Hodgkin's lymphoma.
Jigjidkhorloo N; Kanekura K; Matsubayashi J; Akahane D; Fujita K; Oikawa K; Kurata A; Takanashi M; Endou H; Nagao T; Gotoh A; Norov O; Kuroda M
Sci Rep; 2021 Nov; 11(1):21638. PubMed ID: 34737339
[TBL] [Abstract][Full Text] [Related]
17. Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition.
Uchino H; Kanai Y; Kim DK; Wempe MF; Chairoungdua A; Morimoto E; Anders MW; Endou H
Mol Pharmacol; 2002 Apr; 61(4):729-37. PubMed ID: 11901210
[TBL] [Abstract][Full Text] [Related]
18. Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells.
Kobayashi K; Ohnishi A; Promsuk J; Shimizu S; Kanai Y; Shiokawa Y; Nagane M
Neurosurgery; 2008 Feb; 62(2):493-503; discussion 503-4. PubMed ID: 18382329
[TBL] [Abstract][Full Text] [Related]
19. Aryl hydrocarbon receptor (AHR) regulation of L-Type Amino Acid Transporter 1 (LAT-1) expression in MCF-7 and MDA-MB-231 breast cancer cells.
Tomblin JK; Arthur S; Primerano DA; Chaudhry AR; Fan J; Denvir J; Salisbury TB
Biochem Pharmacol; 2016 Apr; 106():94-103. PubMed ID: 26944194
[TBL] [Abstract][Full Text] [Related]
20. Production of free glutamate in milk requires the leucine transporter LAT1.
Matsumoto T; Nakamura E; Nakamura H; Hirota M; San Gabriel A; Nakamura K; Chotechuang N; Wu G; Uneyama H; Torii K
Am J Physiol Cell Physiol; 2013 Sep; 305(6):C623-31. PubMed ID: 23804198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
